文献速递消化道肿瘤放疗放疗物理与技术

病理完全缓解磁共振影像组学模型在局部进展期直肠癌洲际队列中的适用性

Applicability of a pathological complete response magnetic resonance-based radiomics model for locally advanced rectal cancer in intercontinental cohort.
PubMed 文献 · Radiat Oncol · 2022-04-15

本研究将欧洲开发并验证的基于MRI影像组学的局部进展期直肠癌病理完全缓解预测模型,应用于2017年3月至2018年1月在中国大陆肿瘤中心连续治疗的59例患者进行外部验证;洲际队列AUC为0.83(95%CI 0.71-0.96),采用原模型最佳截断值0.26时准确率0.65、特异度0.64、敏感度0.70、阴性预测值0.91、阳性预测值0.28。作者认为该模型在真实世界欧洲以外患者队列中具有可重复性,达到TRIPOD 4水平。

要点

  • 洲际验证队列AUC为0.83(95%CI 0.71-0.96),原研究外部验证为0.75(95%CI 0.61-0.88)。
  • 按原模型最佳截断值0.26,准确率0.65、特异度0.64、敏感度0.70、阴性预测值0.91、阳性预测值0.28。
  • 作者认为该模型在欧洲以外真实世界队列中具有可重复性,达到TRIPOD 4水平。

核心结论

  • 作者认为,尽管引入显著不同的因素,该模型在真实世界的欧洲以外患者队列中仍表现出可重复性,达到TRIPOD 4水平。

研究设计与样本

  • 本研究为外部验证研究,将欧洲开发并验证的MRI影像组学pCR模型应用于洲际队列。
  • 原模型基于161例局部进展期直肠癌患者新辅助放化疗前采集的T2加权1.5 T MRI,提取2个临床特征和2个影像组学特征作为训练集。
  • 验证队列为2017年3月至2018年1月在中国大陆肿瘤中心连续治疗的59例临床特征不同的局部进展期直肠癌患者,使用T2加权1.5 T和3 T分期MRI。
  • 模型性能以受试者工作特征曲线下面积(AUC)及准确率、特异度、阴性预测值和阳性预测值等相对参数评价。

主要发现

  • 洲际队列AUC为0.83(95%CI 0.71-0.96),原研究外部验证步骤的AUC为0.75(95%CI 0.61-0.88)。
  • 采用原研究确定的最佳截断值0.26时,准确率为0.65、特异度为0.64、敏感度为0.70、阴性预测值为0.91、阳性预测值为0.28。

关键数值与推荐

  • 模型预测pCR的洲际队列AUC为0.83(95%CI 0.71-0.96)。
  • 原研究外部验证AUC为0.75(95%CI 0.61-0.88)。
  • 最佳截断值0.26下:准确率0.65、特异度0.64、敏感度0.70、阴性预测值0.91、阳性预测值0.28。

临床怎么用

  • 作者认为该MRI影像组学pCR模型可在欧洲以外真实世界局部进展期直肠癌患者队列中重复应用,达到TRIPOD 4水平。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Predicting pathological complete response (pCR) in patients affected by locally advanced rectal cancer (LARC) who undergo neoadjuvant chemoradiotherapy (nCRT) is a challenging field of investigation, but many of the published models are burdened by a lack of reliable external validation. Aim of this study was to evaluate the applicability of a magnetic resonance imaging (MRI) radiomic-based pCR model developed and validated in Europe, to a different cohort of patients from an intercontinental cancer center. METHODS: The original model was based on two clinical and two radiomics features extracted from T2-weighted 1.5 T MRI of 161 LARC patients acquired before nCRT, considered as training set. Such model is here validated using the T2-w 1.5 and 3 T staging MRI of 59 LARC patients with different clinical characteristics consecutively treated in mainland Chinese cancer center from March 2017 to January 2018. Model performance were evaluated in terms of area under the receiver operator characteristics curve (AUC) and relative parameters, such as accuracy, specificity, negative and positive predictive value (NPV and PPV). RESULTS: An AUC of 0.83 (CI 95%, 0.71-0.96) was achieved for the intercontinental cohort versus a value of 0.75 (CI 95%, 0.61-0.88) at the external validation step reported in the original experience. Considering the best cut-off threshold identified in the first experience (0.26), the following predictive performance were obtained: 0.65 as accuracy, 0.64 as specificity, 0.70 as sensitivity, 0.91 as NPV and 0.28 as PPV. CONCLUSIONS: Despite the introduction of significant different factors, the proposed model appeared to be replicable on a real-world data extra-European patients' cohort, achieving a TRIPOD 4 level.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Boldrini L, Lenkowicz J, Orlandini LC, et al. Applicability of a pathological complete response magnetic resonance-based radiomics model for locally advanced rectal cancer in intercontinental cohort. Radiat Oncol. 2022. PMID: 35428267. doi:10.1186/s13014-022-02048-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。